Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection

作者: D. Gholobova , M. Gerard , L. Decroix , L. Desender , N. Callewaert

DOI: 10.1038/S41598-018-30123-3

关键词:

摘要: The development of laboratory-grown tissues, referred to as organoids, bio-artificial tissue or tissue-engineered constructs, is clearly expanding. We describe for the first time how engineered human muscles can be applied a pre- non-clinical model intramuscular drug injection further decrease and complement use in vivo animal studies. muscle (BAM) formed seven day engineering procedure during which myoblasts fuse differentiate aligned myofibers an extracellular matrix. dimensions BAM constructs allow follow-up several days after injection. A stereotactic setup allows controllable at multiple sites BAM. injected compounds; dye, hydrolysable compound, reducible substrate wasp venom toxin. Afterwards, direct reflux, release metabolism were assessed comparison 2D cell culture isolated strips. Spectrophotometry luminescence allowed measure compounds their metabolites over time. profile 40 hours was observed contrast culture, showing capacity function depot. also determined compound toxicity on BAMs by measuring creatine kinase medium, increased with increasing toxic insult. Taken together, we show that injectable 3D used vitro.

参考文章(69)
Eleanor F. Evans, Jack D. Proctor, Melvin J. Fratkin, Jorge Velandia, Albert J. Wasserman, Blood flow in muscle groups and drug absorption. Clinical Pharmacology & Therapeutics. ,vol. 17, pp. 44- 47 ,(1975) , 10.1002/CPT197517144
Horst Spielmann, Sebastian Hoffmann, Manfred Liebsch, Phil Botham, Julia H. Fentem, Chantra Eskes, Roland Roguet, José Cotovio, Thomas Cole, Andrew Worth, Jon Heylings, Penny Jones, Catherine Robles, Helena Kandárová, Armin Gamer, Marina Remmele, Rodger Curren, Hans Raabe, Amanda Cockshott, Ingrid Gerner, Valérie Zuang, The ECVAM international validation study on in vitro tests for acute skin irritation, Report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test Atla-alternatives To Laboratory Animals. ,vol. 35, pp. 559- 601 ,(2007) , 10.1177/026119290703500614
Daniela Pacheco, Rui Reis, Vítor Correlo, Alexandra Marques, The Crosstalk between Tissue Engineering and Pharmaceutical Biotechnology: Recent Advances and Future Directions Current Pharmaceutical Biotechnology. ,vol. 16, pp. 1012- 1023 ,(2015) , 10.2174/1389201016666150826120257
Janet Shansky, Paulette Ferland, Sharon McGuire, Courtney Powell, Michael DelTatto, Martin Nackman, James Hennessey, Herman H. Vandenburgh, Tissue Engineering Human Skeletal Muscle for Clinical Applications John Wiley & Sons, Inc.. pp. 239- 257 ,(2006) , 10.1002/0471741817.CH10
Yuan Chen, Jin Y. Jin, Sophie Mukadam, Vikram Malhi, Jane R. Kenny, Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies Biopharmaceutics & Drug Disposition. ,vol. 33, pp. 85- 98 ,(2012) , 10.1002/BDD.1769
Dacha Gholobova, Lieselot Decroix, Vicky Van Muylder, Linda Desender, Melanie Gerard, Gilles Carpentier, Herman Vandenburgh, Lieven Thorrez, Endothelial Network Formation Within Human Tissue-Engineered Skeletal Muscle. Tissue Engineering Part A. ,vol. 21, pp. 2548- 2558 ,(2015) , 10.1089/TEN.TEA.2015.0093
Robert G. Dennis, Paul E. Kosnik, Mark E. Gilbert, John A. Faulkner, Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines American Journal of Physiology-cell Physiology. ,vol. 280, pp. 288- 295 ,(2001) , 10.1152/AJPCELL.2001.280.2.C288
Ismail Kola, John Landis, Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery. ,vol. 3, pp. 711- 716 ,(2004) , 10.1038/NRD1470
Anne Seidlitz, Werner Weitschies, In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing. Journal of Pharmacy and Pharmacology. ,vol. 64, pp. 969- 985 ,(2012) , 10.1111/J.2042-7158.2011.01439.X